We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.4%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$1.67B
(+18%)
Cap. Flow
+$806M
Cap. Flow
% of AUM
7.42%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
678
New
211
Increased
171
Reduced
126
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ERF
Enerplus Corporation
ERF
|
+$91.2M |
| 2 |
TE Connectivity
TEL
|
+$81.6M |
| 3 |
Palo Alto Networks
PANW
|
+$78.9M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$75.6M |
| 5 |
Honeywell
HON
|
+$70.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$113M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
+$88.1M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$70.1M |
| 5 |
Synopsys
SNPS
|
+$64.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.5% |
| 2 | Technology | 22.75% |
| 3 | Industrials | 9.82% |
| 4 | Energy | 8.34% |
| 5 | Consumer Discretionary | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Hubbell
HUBB
$26.8B
| $10.9M | 0.1% |
26,226
-82,020
| -76% | -$29.7M |
|
252
Curtiss-Wright
CW
$26.4B
| $10.8M | 0.1% |
42,134
+34,705
| +467% | +$8.07M |
|
|
MRNS
253
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $10.7M | 0.1% |
1,186,781
+386,781
| +48% | +$3.76M |
|
254
Meritage Homes
MTH
$4.71B
| $10.7M | 0.1% |
+122,212
| New | +$9.89M |
|
|
SMAR
255
DELISTED
Smartsheet Inc.
SMAR
| $10.7M | 0.1% |
277,135
+101,773
| +58% | +$4.44M |
|
256
Viatris
VTRS
$19B
| $10.6M | 0.1% |
889,500
-1,403,596
| -61% | -$16.9M |
|
257
Choice Hotels
CHH
$4.99B
| $10.6M | 0.1% |
83,692
+15,652
| +23% | +$1.87M |
|
258
Arbutus Biopharma
ABUS
$897M
| $10.5M | 0.1% |
4,070,659
-649,244
| -14% | -$1.68M |
|
259
Vulcan Materials
VMC
$36.5B
| $10.5M | 0.1% |
+38,416
| New | +$9.47M |
|
|
HA
260
DELISTED
Hawaiian Holdings, Inc.
HA
| $10.5M | 0.1% |
785,417
-63,629
| -7% | -$885K |
|
|
P
261
Everpure Inc
P
$29B
| $10.4M | 0.1% |
200,880
-365,370
| -65% | -$16.3M |
|
262
Denali Therapeutics
DNLI
$3.92B
| $10.4M | 0.1% |
508,565
+310,981
| +157% | +$5.84M |
|
263
MoonLake Immunotherapeutics
MLTX
$1.53B
| $10.4M | 0.1% |
207,415
+85,661
| +70% | +$4.65M |
|
|
WCC
264
WESCO International
WCC
$18.1B
| $10.3M | 0.09% |
+59,890
| New | +$9.9M |
|
265
Novartis
NVS
$293B
| $10.2M | 0.09% |
+105,656
| New | +$10.8M |
|
266
Armstrong World Industries
AWI
$7.78B
| $10.2M | 0.09% |
81,817
-72,949
| -47% | -$8.05M |
|
267
Universal Health Services
UHS
$10.3B
| $10.2M | 0.09% |
55,657
-106,743
| -66% | -$17.6M |
|
|
ALPN
268
DELISTED
Alpine Immune Sciences Inc
ALPN
| $10.1M | 0.09% |
254,334
-745,772
| -75% | -$22M |
|
269
ServiceNow
NOW
$121B
| $10.1M | 0.09% |
+66,035
| New | +$10M |
|
|
SEM
270
DELISTED
Select Medical
SEM
| $10M | 0.09% |
+616,817
| New | +$9.03M |
|
271
Ambarella
AMBA
$3.68B
| $9.96M | 0.09% |
+196,084
| New | +$10.7M |
|
272
EyePoint Inc
EYPT
$1.08B
| $9.92M | 0.09% |
479,682
+79,682
| +20% | +$1.97M |
|
273
PagerDuty
PD
$856M
| $9.87M | 0.09% |
+435,401
| New | +$10.3M |
|
274
FedEx
FDX
$74.7B
| $9.83M | 0.09% |
33,935
-27,444
| -45% | -$6.87M |
|
275
Kyverna Therapeutics
KYTX
$471M
| $9.76M | 0.09% |
+392,928
| New | +$11M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q1 2024 Portfolio in Review
As of Q1 2024, Woodline Partners held 678 positions worth $10.9B, up 18% from $9.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Woodline Partners deployed $806M of net new capital in Q1 2024, opening 211 new positions and adding to 171 existing holdings. Its largest new stake was Enerplus Corporation: 5,602,613 shares worth $110M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $110M trimmed.
- Woodline Partners's largest Q1 2024 buy was Enerplus Corporation: 5,602,613 shares worth $110M.
- Woodline Partners added most to TE Connectivity in Q1 2024, an estimated $81.6M increase.
- Woodline Partners's biggest Q1 2024 reduction was AbbVie, cutting an estimated $110M.
- Woodline Partners fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $113M.
- Woodline Partners's ten largest holdings make up 14% of its $10.9B portfolio in Q1 2024.
- Woodline Partners opened 211 new positions and closed 150 in Q1 2024.
- Woodline Partners's portfolio value rose 18% quarter-over-quarter to $10.9B.
Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.